Spectranetics rids board of "underinvestors", price tumbles
This article was originally published in Clinica
US laser developer Spectranetics (Colorado Springs, Colorado) last week confronted divisions emerging within the board by removing two dissenters, CEO Joseph Largey and CFO Paul Samek. Both had disagreed with board policy, said the board in a statement. It said that the two directors were not committed to getting expenses under control, and were "underinvesting in product development at a critical point". Share prices dropped 20% on the development.
You may also be interested in...
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.